Galapagos NV Sponsored ADR GLPG 深 沪
已收盘 05-07 16:00:00 美东时间
27.73
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 27.73
- 总市值 18.27亿
- 52周最高 37.78
- 市盈率 静 5.05
- 换手率 0.00%
- 52周最低 26.62
- 委 比 0.00%
- 总股本 6589.71万
- 历史最高 274.03
- 量 比 0
- 振 幅 0.00%
- 历史最低 13.023
- 每 手 1
- 风险率 2.11%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Earnings Scheduled For May 6, 2026
Companies Reporting Before The Bell • Deluxe (NYSE:DLX) is expected to report q...
05-07 05:03
Galapagos Q1 EPS US$0.25 Beats US$(1.27) Estimate, Sales US$7.589M Miss US$16.040M Estimate
Galapagos (NASDAQ:GLPG) reported quarterly earnings of $0.25 per share which beat the analyst consensus estimate of $(1.27) by 119.69 percent. This is a 110.12 percent increase over losses of $(2.47) per share from the
05-07 04:03
Reported Earlier, Galapagos Eyes Strategic Collaboration With Gilead On T Cell Engager Program After $1.675B Ouro Acquisition With Additional $500M Milestone Payments
Galapagos intends to enter into a strategic collaboration with Gilead following Gilead's acquisition of Ouro MedicinesNew partnership structure would achieve meaningfully improved financial terms and flexibility for
03-24 15:39
Galapagos NV Board Creates 1.75M Subscription Rights Under New Subscription Right Plan
Galapagos NV ((Euronext &, NASDAQ:GLPG) announced today that its Board of Directors created 1,750,000 subscription rights under a new subscription right plan.On March 6, 2026, the
03-07 05:06
美股大行评级 | 大摩将应用材料目标价升至432美元；潜在涨幅200.0%！维尔生物科技获巴克莱升目标价至30美元，维持"超配"评级
今日重点评级关注：巴克莱：维持Vir Biotechnology"超配"评级，目标价从26美元升至30美元；巴克莱：维持Iovance Biotherapeutics"超配"评级，目标价从10美元升至11美元
02-26 09:30
RBC Capital Maintains Sector Perform on Galapagos, Raises Price Target to $33
RBC Capital analyst Brian Abrahams maintains Galapagos (NASDAQ:GLPG) with a Sector Perform and raises the price target from $32 to $33.
02-25 23:49
Earnings Breakdown: Galapagos Q4
Galapagos (NASDAQ:GLPG) announced its Q4 earnings on Monday, February 23, 2026 ...
02-24 05:52
Galapagos Q4 EPS $13.82 increased from $0.30, Sales $1.049B increased from $80.575M
Galapagos (NASDAQ:GLPG) reported quarterly earnings of $13.82 per share. This is a 4506 percent increase over earnings of $0.30 per share from the same period last year. The company reported quarterly sales of $1.049
02-24 05:50
Earnings Scheduled For February 23, 2026
Companies Reporting Before The Bell • Domino's Pizza (NASDAQ:DPZ) is likely to ...
02-23 19:11
Galapagos To Wind Down Cell Therapy Business After Works Council Approval, Impacting ~365 Jobs And Closing Multiple Global Sites
Galapagos NV ((Euronext &, NASDAQ:GLPG) today announced that the works council consultation process regarding the wind-down of cell therapy activities has been completed and its Board of Directors has decided to
01-06 05:02
